Vyvanse Regret, Stopping, and Restarting: What Real Users and Clinical Data Actually Show

Why People Regret Starting Vyvanse

People who regret starting Vyvanse most often point to side effects that showed up in the first two to four weeks and felt worse than the condition being treated. The top complaints tracked across Drugs.com reviews, Reddit's r/ADHD and r/Vyvanse threads, and published adverse-event data line up closely with each other.

The Side Effects That Drive Early Regret

The FDA prescribing information for lisdexamfetamine lists the following adverse reactions occurring in 5% or more of adult ADHD patients in controlled trials: decreased appetite (39%), insomnia (19%), dry mouth (26%), headache (20%), and irritability (10%) [1]. Those numbers come from short trials, typically 4 to 13 weeks. In practice, appetite suppression and sleep disruption are the two effects people most frequently describe as dealbreakers in real-world posts.

Cardiovascular concern is a separate thread. A 2023 JAMA Psychiatry study (N=278,000 Swedish registry participants) found that ADHD stimulant use was associated with a statistically significant increase in cardiovascular events over a 14-year follow-up period, though the absolute risk remained low in individuals without preexisting cardiac conditions [2]. That finding, when shared on social media, has driven a wave of people stopping abruptly out of fear.

Emotional Blunting and "Zombie Feeling"

Emotional blunting is less well-studied but clinically recognized. An analysis published in the Journal of Child and Adolescent Psychopharmacology noted that stimulant-related emotional constriction occurs in roughly 20 to 30% of patients and resolves with dose reduction in the majority of cases [3]. This is not a reason to abandon the medication class outright, but it is a reason to call your prescriber before quitting.

The "It Changed My Personality" Experience

Some users describe feeling productive but flat, like a quieter version of themselves. This experience correlates with higher doses. Stepping from 70 mg down to 50 mg or 40 mg often restores emotional range without sacrificing focus, according to clinical guidance from the American Academy of Child and Adolescent Psychiatry.

Why People Regret Stopping Vyvanse

The regret runs both directions. A large share of Reddit threads about Vyvanse follow a pattern: the person quits, feels relief from side effects for a week or two, then watches their ADHD symptoms return hard. Executive dysfunction, task paralysis, emotional dysregulation, and re-emergence of binge eating in BED patients are the most-cited reasons people wish they had stayed on the medication or restarted sooner.

ADHD Symptoms Return Without Warning

Lisdexamfetamine has no meaningful accumulation in the body. It converts to d-amphetamine in the bloodstream, and within 24 to 48 hours of the last dose, plasma levels are negligible [4]. That means ADHD symptoms return roughly two days after stopping, not gradually over weeks. Many users are surprised by how fast the cognitive fog returns.

The ADHD-200 consortium data and the CADDRA Canadian ADHD Resource Alliance guidelines both note that untreated adult ADHD is associated with substantially higher rates of unemployment, relationship disruption, and motor vehicle accidents compared to treated adults [5]. That context matters when someone is weighing whether to restart.

Binge Eating Disorder Relapse After Stopping

Vyvanse is the only FDA-approved pharmacotherapy for moderate-to-severe binge eating disorder in adults. In the key Phase 3 trials (SPD489-343 and SPD489-344, combined N=773), lisdexamfetamine produced a 78.7% responder rate on binge-day reduction at week 12 versus 48.7% for placebo [6]. Post-discontinuation relapse rates are not well-characterized in the published literature, but clinical case series suggest that binge episodes return within two to four weeks of stopping in most patients who had responded.

The Withdrawal Reality

Stopping Vyvanse abruptly is not dangerous for most people, but it is uncomfortable. The FDA label describes a "rebound" phenomenon in which amphetamine withdrawal produces fatigue, depression, and increased appetite [1]. This rebound is physiological, not a moral failure, and lasts three to seven days in most cases before a new neurochemical baseline is established. Knowing this timeline helps people not misinterpret the withdrawal crash as proof that the medication was their only source of normal functioning.

Does Vyvanse Stop Working Over Time?

Tolerance to lisdexamfetamine is one of the most debated topics in ADHD forums. The clinical answer is more specific than the forum conversations suggest.

What the Evidence Says About Tolerance

True pharmacological tolerance, meaning the drug produces less receptor response at the same dose, does develop with chronic amphetamine use [7]. However, a perceived "wearing off" is more commonly explained by dose mismatch (weight change, hormonal fluctuations), lifestyle factors (poor sleep, high stress), or the placebo-adjacent lift of novelty fading. A six-month maintenance trial (NCT00552305) found that lisdexamfetamine maintained statistically significant ADHD symptom control at 70 mg versus placebo at week 26, with no significant erosion of effect over that period [8].

When a Dose Increase Makes Sense

A dose increase from, say, 50 mg to 60 mg may restore efficacy if a patient has gained 15 to 20 pounds since their last titration. Weight-based dosing is not formally required for lisdexamfetamine, but body mass influences amphetamine distribution volume, and the maximum approved dose of 70 mg is a regulatory ceiling, not a pharmacokinetic one. Discuss any perceived tolerance with your prescriber before self-adjusting.

"Drug Holidays" and Their Real Effect

Some clinicians recommend weekend or summer breaks from stimulants to reset sensitivity and allow growth in pediatric patients. For adults, drug holidays may reduce side-effect burden (improved appetite, sleep) but carry the cost of unmanaged ADHD symptoms on break days. A Cochrane review of stimulant medication in ADHD found insufficient high-quality evidence to recommend routine drug holidays in adults, though individual benefit-risk weighing remains appropriate [9].

How to Stop Vyvanse Safely

Abrupt cessation is medically safe for most patients, but a structured taper reduces crash severity.

A Practical Tapering Approach

A commonly used clinical approach is reducing by one dose tier (e.g., 70 mg to 60 mg) every one to two weeks. Since lisdexamfetamine capsules can be opened and the powder dissolved in water for precise partial dosing, dose reductions below the available capsule sizes are achievable in practice. This is off-label but described in clinical case reports and supported by the FDA label's note that the capsule contents may be dissolved in water [1].

Timing the Stop

The best time to stop, if stopping is elective, is during a period of lower cognitive demand. Starting a taper the week before a major work deadline increases the likelihood of regret. Scheduling a follow-up appointment two weeks after the last dose gives a clinician a chance to assess whether symptoms returning are tolerable or impair function.

What to Tell Your Prescriber

Telling your prescriber you want to stop because of a specific side effect (insomnia, appetite loss, anxiety) opens the door to solutions short of full discontinuation: dose reduction, switching to a different stimulant formulation, or adjunctive treatment. Telling them only that it "isn't working" closes that door faster.

Restarting Vyvanse After a Break

Restarting Vyvanse is generally safe and effective, provided the original ADHD or BED diagnosis was sound. There is no published randomized controlled trial specifically examining lisdexamfetamine restart outcomes, but the pharmacology supports the following approach used by most clinicians.

The Standard Restart Protocol

Most prescribers restart at the lowest effective prior dose or one tier below it, rather than jumping back to the dose that was being taken before the break. The rationale is that a break of four or more weeks allows partial reversal of any tolerance that had accumulated, meaning the previous dose may now feel stronger. Starting at 30 mg or 40 mg for two weeks before re-titrating upward avoids the jarring re-entry effect that some users describe when jumping straight back to 70 mg.

A reasonable restart framework:

• Break of 1 to 4 weeks: Restart at the last effective dose. Monitor cardiovascular response for the first week.
• Break of 4 to 12 weeks: Drop one dose tier below the last effective dose. Re-titrate over 2 to 4 weeks as tolerated.
• Break of 3 months or longer: Restart at 20 mg to 30 mg. Re-titrate slowly. Consider re-evaluating the ADHD diagnosis with updated rating scales.

Lab and Cardiac Checks Before Restarting

Blood pressure and heart rate should be documented before restarting. The American Heart Association and the American Academy of Pediatrics recommend a cardiac history review and blood pressure measurement before starting or restarting any stimulant [10]. An EKG is not routinely required in the absence of personal or family history of structural heart disease.

When Restarting May Not Be the Right Answer

If Vyvanse was stopped because of cardiovascular side effects (hypertension above 140/90, resting tachycardia above 100 bpm, chest pain, palpitations), a non-stimulant alternative such as atomoxetine or viloxazine should be discussed before restarting the same medication. Atomoxetine (Strattera) produced ADHD symptom improvement in adults in a meta-analysis of 25 trials, though the effect size was smaller than for stimulants (standardized mean difference 0.49 versus 0.70 to 0.80 for amphetamines) [11].

What Reddit and Real-User Reviews Actually Reveal

Reddit's r/ADHD (4.3 million members as of mid-2025) and r/Vyvanse generate thousands of posts about stopping and restarting. The signal in those threads, when you read past the individual variation, is fairly consistent.

The Most Common Reddit Patterns

The most-upvoted posts in "I stopped Vyvanse" threads follow a predictable arc. Days 1 to 3: relief, feeling "more like myself," better appetite. Days 4 to 10: fatigue, inability to complete tasks, emotional dysregulation. Weeks 2 to 4: either adaptation (for people whose ADHD was mild or questionable) or a return to prescriber. This arc matches the pharmacological timeline almost exactly.

On Drugs.com, Vyvanse carries an average rating of 7.3 out of 10 across 1,687 reviews as of 2024 [12]. Among the negative reviews, the two most common categories are "worked initially, stopped working" and "side effects outweighed the benefit." Among positive reviews, "life-changing for executive function" and "finally able to finish things" dominate.

The Selection Bias Problem

Forum data skews toward people having strong reactions, positive or negative. A person whose Vyvanse dose is quietly working at 40 mg and who has no complaints is not posting daily threads. A 2021 analysis in Neuropsychiatric Disease and Treatment cautioned that online ADHD medication reviews significantly overrepresent adverse outcomes compared to clinical trial adverse-event rates, because clinical participants are screened and monitored more carefully [13]. Use forum data for hypothesis generation, not clinical decision-making.

Does Vyvanse Work for Everyone?

No medication works for everyone. In the key adult ADHD trial (SPD489-304, N=358), 56.8% of lisdexamfetamine patients were classified as responders (50% or greater reduction in ADHD-RS-IV score) at week 4, versus 19.4% on placebo [14]. That means roughly 43% of patients on active drug did not meet the responder threshold by that definition, though many experienced partial benefit.

Predictors of poorer response include comorbid untreated anxiety, active substance use disorder, significant sleep deprivation, and incorrect diagnosis. A patient misdiagnosed with ADHD who actually has bipolar II disorder, thyroid dysfunction, or sleep apnea will not get meaningful, sustained benefit from lisdexamfetamine, and may experience worsened mood instability.

The 2023 NICE guidelines for ADHD in adults recommend that if a stimulant does not produce clear benefit within an adequate trial at an adequate dose, the prescriber should revisit the diagnosis before escalating or switching [15].

Clinical Takeaways for People Considering Stopping or Restarting

Stopping and restarting Vyvanse are common, often necessary parts of finding the right long-term ADHD management approach. Regret, in either direction, usually comes from making the decision without a structured plan. A prescriber conversation before stopping is more useful than one after. If restarting after a break of three months or more, begin at 20 mg to 30 mg and re-titrate over four weeks, with a blood pressure check at baseline and at week 2.